Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Savara Inc., 3 years.
Savara Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | Halozyme Therapeutics Inc. | Option exercise | +10,000 | — | — |
| Jun 30, 2026 | Halozyme Therapeutics Inc. | Shares withheld for tax | −5,408 | $78.27 | $423,284 |
| Dec 19, 2025 | Savara Inc. | Open-market sale | −20,000 | $6.06 | $121,200 |
| Dec 9, 2025 | Savara Inc. | Grant or award | +40,000 | — | — |
| Mar 31, 2025 | Savara Inc. | Open-market purchase | +150,000 | $2.78 | $417,000 |
| Dec 12, 2024 | Savara Inc. | Grant or award | +40,000 | — | — |
| Nov 18, 2024 | Savara Inc. | Open-market purchase | +100,000 | $2.88 | $288,000 |
| Dec 14, 2023 | Savara Inc. | Grant or award | +22,500 | — | — |
| May 26, 2023 | Savara Inc. | Open-market purchase | +37,124 | $2.63 | $97,636 |
| May 25, 2023 | Savara Inc. | Open-market purchase | +12,876 | $2.57 | $33,091 |
| May 24, 2023 | Savara Inc. | Open-market purchase | +50,000 | $2.56 | $128,000 |
| Dec 30, 2022 | Savara Inc. | Open-market purchase | +29,000 | $1.55 | $44,950 |
| Dec 29, 2022 | Savara Inc. | Open-market purchase | +7,000 | $1.54 | $10,780 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.